Vaccine can wipe out lung cancer, say researchers

AN experimental vaccine wiped out lung cancer in some patients and slowed its spread in others in a small but promising study, researchers said today.

Three patients injected with the vaccine, GVAX, had no recurrence of lung cancer for more than three years afterward, according to the study of 43 people with the most common form of the disease, non-small cell lung cancer.

The findings were published in the US Journal of the National Cancer Institute. The research was part-funded by CellGenesis, a pharmaceutical firm hoping to make the vaccine.